M
Measles (Rubeola)
-
Definition: Highly contagious viral infection caused by measles virus.
-
Epidemiology: Peak incidence in children 6 months–5 years; outbreaks in areas with low vaccination coverage.
-
Clinical Features:
-
Prodrome: Fever, cough, coryza, conjunctivitis.
-
Koplik spots (white lesions on buccal mucosa).
-
Maculopapular rash starting at the face, spreading cephalocaudally.
-
-
Complications: Otitis media, pneumonia, diarrhea, encephalitis, subacute sclerosing panencephalitis (rare).
-
Investigations: Clinical diagnosis; serology (IgM antibodies) for confirmation.
-
Management: Supportive: hydration, antipyretics, vitamin A supplementation.
-
Prevention: Measles-containing vaccines (MMR).
Meningitis (Pediatric)
-
Definition: Inflammation of meninges, usually infectious.
-
Etiology:
-
Bacterial: Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b.
-
Viral: Enteroviruses (most common overall).
-
-
Clinical Features: Fever, irritability, poor feeding, bulging fontanelle (infants), nuchal rigidity, vomiting, seizures.
-
Investigations: CBC, CRP, blood culture, lumbar puncture (CSF analysis: cell count, glucose, protein, culture).
-
Management:
-
Bacterial: Empirical IV antibiotics (ceftriaxone/vancomycin) immediately.
-
Viral: Supportive care.
-
-
Complications: Hearing loss, neurologic deficits, hydrocephalus, death.
-
Prevention: Vaccination (Hib, pneumococcal, meningococcal).
Meningococcemia
-
Definition: Systemic infection with Neisseria meningitidis causing sepsis and purpura fulminans.
-
Clinical Features: Fever, hypotension, petechial/purpuric rash, DIC, multi-organ failure.
-
Investigations: Blood cultures, coagulation profile, CBC.
-
Management: Rapid IV antibiotics (ceftriaxone/penicillin), supportive care in ICU, manage DIC.
-
Prevention: Vaccination (quadrivalent meningococcal, MenB).
Metabolic Disorders (Pediatric)
-
Definition: Genetic or acquired disorders affecting metabolism.
-
Common Examples:
-
Phenylketonuria (PKU)
-
Maple syrup urine disease
-
Galactosemia
-
Urea cycle defects
-
-
Clinical Features: Feeding difficulties, vomiting, developmental delay, lethargy, seizures, failure to thrive.
-
Investigations: Newborn screening, plasma amino acids, urine organic acids, enzyme assays.
-
Management: Dietary restriction, supplementation, emergency metabolic management.
Microcephaly
-
Definition: Head circumference <2 SD below mean for age and sex.
-
Etiology: Genetic syndromes, congenital infections (TORCH), perinatal hypoxia, metabolic disorders.
-
Clinical Features: Small head, developmental delay, neurologic deficits, seizures.
-
Investigations: Head circumference charts, neuroimaging (MRI/CT), genetic testing, metabolic work-up.
-
Management: Symptomatic and supportive: physiotherapy, occupational therapy, management of seizures, special education.
Molluscum Contagiosum
-
Definition: Self-limiting viral skin infection caused by a poxvirus.
-
Clinical Features: Small, flesh-colored, dome-shaped papules with central umbilication, commonly on trunk, extremities, face.
-
Investigations: Clinical diagnosis.
-
Management: Usually resolves spontaneously; curettage, cryotherapy, or topical therapy (imiquimod) for cosmetic or persistent cases.
Mononucleosis (Epstein-Barr Virus Infection)
-
Definition: Acute lymphoproliferative disease caused by EBV.
-
Clinical Features: Fever, pharyngitis, lymphadenopathy (cervical), splenomegaly, fatigue, hepatomegaly.
-
Investigations: Heterophile antibody test (Monospot), EBV serology, CBC showing atypical lymphocytes.
-
Management: Supportive care, analgesics, hydration, avoid contact sports due to splenomegaly.
-
Complications: Hemolytic anemia, thrombocytopenia, airway obstruction (rare).
Muscular Dystrophies (Pediatric)
-
Definition: Group of inherited disorders causing progressive muscle weakness.
-
Common Types:
-
Duchenne Muscular Dystrophy (DMD): X-linked recessive, onset 2–5 years, calf pseudohypertrophy, Gower sign, rapid progression.
-
Becker Muscular Dystrophy: Milder, later onset, slower progression.
-
-
Investigations: CK elevation, genetic testing (dystrophin gene), EMG, muscle biopsy.
-
Management: Corticosteroids, physiotherapy, orthopedic interventions, cardiac and respiratory monitoring.
-
Prognosis: DMD: wheelchair-bound by early teens, life expectancy reduced; Becker: variable.
Myasthenia Gravis (Juvenile)
-
Definition: Autoimmune disorder affecting neuromuscular junction causing muscle weakness.
-
Clinical Features: Ptosis, diplopia, generalized weakness, fatigability, dysphagia.
-
Investigations: Acetylcholine receptor antibodies, EMG, repetitive nerve stimulation, thymus imaging.
-
Management: Acetylcholinesterase inhibitors (pyridostigmine), immunosuppressants (steroids, azathioprine), thymectomy in selected cases.
Myocarditis (Pediatric)
-
Definition: Inflammation of the heart muscle, usually viral in children.
-
Clinical Features: Fatigue, tachycardia, dyspnea, chest pain, palpitations, signs of heart failure.
-
Investigations: ECG (ST-T changes, arrhythmias), echocardiography, cardiac biomarkers (troponin), MRI.
-
Management: Supportive care (heart failure management), immunomodulation in selected cases, monitoring for arrhythmias.
-
Complications: Dilated cardiomyopathy, arrhythmias, sudden death.
Meningomyelocele
-
Definition: Severe form of spina bifida where meninges and spinal cord protrude through vertebral defect.
-
Clinical Features: Visible sac at birth, lower limb weakness or paralysis, bladder/bowel dysfunction, orthopedic deformities.
-
Investigations: Prenatal ultrasound, postnatal MRI/CT, neurologic assessment.
-
Management: Early surgical closure, multidisciplinary care (neurosurgery, orthopedics, urology, physiotherapy).
-
Complications: Hydrocephalus, infection, paralysis, tethered cord syndrome.
Methemoglobinemia (Pediatric)
-
Definition: Elevated methemoglobin (>1–2% normal), reducing oxygen-carrying capacity of blood.
-
Etiology: Congenital (enzyme deficiency), acquired (drugs, chemicals).
-
Clinical Features: Cyanosis unresponsive to oxygen, fatigue, tachypnea, neurologic symptoms in severe cases.
-
Investigations: Co-oximetry, blood gas analysis, methemoglobin levels.
-
Management: Remove offending agent, methylene blue for severe cases, supportive oxygen therapy.